Status:

COMPLETED

A Mixed Methods Evaluation of HPI Resilience Intervention Study

Lead Sponsor:

Johnson & Johnson Health and Wellness Solutions, Inc.

Collaborating Sponsors:

Lake Nona Institute

Grounded Solutions Ltd

Conditions:

Stress

Eligibility:

All Genders

18-110 years

Phase:

NA

Brief Summary

The primary objective of the Resilience Study is to determine the impact of the Corporate Athlete® Resilience product through recalibrating mindset and changing resilience supportive behavior. Analys...

Detailed Description

Methodology: This is an interventional mixed methods (qualitative \& quantitative) study, with pre-post design for research participants in one session. All participants will be measured at two ti...

Eligibility Criteria

Inclusion

  • Be an adult (18 years or older);
  • Be a participant in the LNLP (i.e., provided consent for the project);
  • Meet =\>2 stress experience level parameters on Stress Mindset Measure-General (SMM-G);
  • Meet =\< 4.3 on the Brief Resilience Scale (BRS);
  • Be willing to attend a full day training program at the Lake Nona Institute during the designated training date;
  • Be willing to provide email and phone number as a contact method;
  • Must speak, read, and understand English fluently;
  • Be able to comprehend and follow the requirements of the study;
  • Research Participant must have a valid e-mail address;
  • Be able to provide Informed Consent;
  • Be willing and able to comply with all study procedures for the duration of the study.

Exclusion

  • Is not an adult (18 years or older);
  • Has not consented to participate in the LNLP;
  • Does not meet the stress or resilience parameters (as defined above);
  • Unwilling or unable to provide consent and sign the ICF;
  • Unwilling or unable to complete study related questionnaires;
  • Have a physical or cognitive impairment that would interfere with their ability to provide accurate information;
  • Not able to speak, read, or understand English fluently.

Key Trial Info

Start Date :

September 16 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2017

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03451240

Start Date

September 16 2017

End Date

December 31 2017

Last Update

March 1 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Human Performance Institute

Orlando, Florida, United States, 32827